Finally, a significant increase in FMO1 and LPL expression levels and a decrease in AMDHD1 and P4HA1 expression levels were observed in patients in the NASH group compared to the HC group. This evidence concerns the gene P4HA1 and metabolic dysfunction-associated steatohepatitis.